Conventional and novel agents in the pharmacotherapy of depression

dc.contributor.advisorSzentmiklósi, József András
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorHannesdóttir, Sunna Kristín
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentPórszász, Róbert
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.date.accessioned2019-09-25T08:56:37Z
dc.date.available2019-09-25T08:56:37Z
dc.date.created2018
dc.description.abstractDepression is the most common mental illness worldwide, affecting more than 300 million people. It is characterized by loss of interest and pleasure, sadness, disturbed sleep pattern and appetite, fatigue and poor concentration, among others. In this review, I discuss the probable etiology, epidemiology, classification, symptoms, diagnosis, risk factors and treatment of depression. My main focus is on the pharmacotherapy of depression with a special reference to selective serotonin reuptake inhibitors (SSRIs). Finally, I describe other pharmacological treatment options as well as some non-pharmacological alternatives.hu_HU
dc.description.correctorhbk
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.coursespecOrvosbiológia-farmakológiahu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent39hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/273722
dc.language.isoenhu_HU
dc.subjectPharmacologyhu_HU
dc.subjectPharmacotherapyhu_HU
dc.subjectDepressionhu_HU
dc.subjectAntidepressantshu_HU
dc.subjectSelective Serotonin Reuptake Inhibitorshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleConventional and novel agents in the pharmacotherapy of depressionhu_HU
Fájlok